CliffBio

Shorla Pharma

Patent cliffs & loss of exclusivity

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. JYLAMVOMETHOTREXATESmall mol.Oct 2035
  2. TEPYLUTETHIOTEPASmall mol.Aug 2041
  3. TEPYLUTETHIOTEPASmall mol.Aug 2041
  4. NELARABINENELARABINESmall mol.—
  5. NELARABINENELARABINESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.